ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

Solvay Specialty Polymers Announces Availability of Solviva® Biomaterials in Brazil

Print | 
Email |  Comment   Share  

Solvay Advanced Polymers, LLC
3702 Clanton Rd.
Augusta, GA, 30916
USA



Press release date: December 4, 2013

Latest Expansion Targets Growing Brazilian Demand for Thermoplastic

Biomaterials in Orthopedic and Cardiovascular Applications

ALPHARETTA, Ga., – The SolvivaŽ Biomaterials line of high-performance plastics for implantable applications – manufactured by Solvay Specialty Polymers - is now commercially available in Brazil, the company has announced. The biomaterials line, previously available in the U.S. and Europe and also recently launched in China, is targeted to meet growing demand in the Brazilian market, complementing Solvay’s already extensive healthcare offering in Brazil which includes medical polymers for non-implantable uses.

Following its recent expansion in China, Solvay is poised to take the next step in its global business strategy and expand the SolvivaŽ Biomaterials line in the growing Brazilian market, according to Maria Gallahue-Worl, Global Industry Manager-Healthcare for Solvay Specialty Polymers. “With our broad product portfolio we are firmly positioned as a strategic supplier to the Brazilian healthcare industry and this expansion in biomaterials signals our further commitment to the global market,” said Gallahue-Worl. “We are leveraging our position as a leading supplier of high-performance polymers to support applications from instrumentation to implants.” SolvivaŽ Biomaterials will primarily be targeted at orthopedic and cardiovascular applications.

New availability for its SolvivaŽ Biomaterials in Brazil will unlock key business opportunities and firmly position the company for future growth, said Gallahue-Worl. Solvay will serve the Brazilian market from its Sao Paulo facility. The company will continue to assess the global market and examine other potential expansions in key geographic regions.

Solvay’s commercial success in the U.S. and Europe with SolvivaŽ Biomaterials is highlighted by the growing use of ZenivaŽ PEEK in the spinal fusion market. ZenivaŽ PEEK boasts a modulus very close to that of bone plus excellent biocompatibility, toughness, and fatigue resistance. For implantable medical devices, the SolvivaŽ Biomaterials line also includes PronivaŽ self-reinforced polyphenylene (SRP), one of the world’s stiffest and strongest unreinforced thermoplastics which offers exceptional biocompatibility and hardness; VerivaŽ polyphenylsulfone (PPSU), which provides unsurpassed toughness combined with transparency and excellent biocompatibility; and EvivaŽ polysulfone (PSU), which offers practical toughness in a strong, transparent polymer.

SolvivaŽ Biomaterials can be sterilized via all conventional methods including gamma radiation, ethylene oxide, and steam. These products are available in resin for injection molding or extrusion, as well as stock shapes for machined components.

The entire line of thermoplastic SolvivaŽ Biomaterials is manufactured in compliance with the relevant aspects of ISO 13485 and under the relevant aspects of current Good Manufacturing Practices. Solvay’s biomaterial manufacturing processes are carefully validated and enhanced controls provide product traceability. In addition, all materials are tested in an accredited lab that is ISO 17025 compliant.

Solvay’s experience as a key materials supplier in the healthcare field spans more than 25 years. The company is a leading manufacturer of high-performance plastics, offering a broad range of materials for healthcare instruments and medical devices, along with its line of SolvivaŽ Biomaterials for implantable devices.

The company is a full-service supplier, providing design support, technical service, and application development support for the global healthcare market. Solvay also continues to devote considerable research and development activities to polymer technology and commercialization of new and unique material options for medical OEMs and processors.

About Solvay Specialty Polymers
Solvay Specialty Polymers (www.solvayspecialtypolymers.com) is a leading global supplier of high-performance thermoplastics for implantable and non-implantable medical devices. The company has expanded its focus on the healthcare industry to meet the growing needs of its global customers. Solvay is building on its 20-year history as a key material supplier in the healthcare field, devoting considerable new resources to help customers be more efficient and cut costs. Metal-to-plastic replacement remains a key focus for manufacturers, but increased cost pressures pose a new challenge as the market continues to grow at a double-digit pace. Solvay also continues to devote considerable research and development activities to polymer technology and commercialization of new and unique material options for medical OEMs and processors.

Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, aromatic ultra polymers, high-barrier polymers and cross-linked high-performance compounds – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire and Cable, and other industries. Learn more at www.solvay.com.

Solvay (www.solvay.com) is an international chemical Group committed to sustainable development with a clear focus on innovation and operational excellence. It is realizing over 90% of its sales in markets where it is among the top 3 global leaders. Solvay offers a broad range of products that contribute to improving quality of life and the performance of its customers in markets such as consumer goods, construction, automotive, energy, water and environment, and electronics. The Group is headquartered in Brussels and its companies, which employ about 31,000 people in 55 countries, generated EUR 12.7 billion in net sales in 2011 (pro forma). Solvay SA is listed as SOLB.BE on NYSE Euronext (www.euronext.com) in Brussels and Paris. Bloomberg (www.bloomberg.com) = SOLB.BB. Reuters (www.reuters.com) = SOLB.BR.

Press Contact:
Joseph Grande
Media Relations
413.684.2463
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
 Visit Green and Clean Blog
  Latest from the Green and Clean Blog
 See more product news in:
Materials and Material Processing
Green & Clean
 More New Product News from this company:
Polysulfone Foam is designed for wire and cable applications.
Polymer Extrusion Material produces ultra-thin films.
PEEK Grade suits wire and cable insulation applications.
More ....
| Featured Manufacturing Jobs
 Other News from this company:
Technifab's New Aerospace Ducting System Features End Caps and Anchors Made of Solvay's AvaSpireŽ PAEK
Solvay Specialty Polymers' KetaSpireŽ PEEK Products are Qualified at Airbus
Arevo Labs Announces Carbon Fiber and Nanotube-Reinforced High Performance Materials for 3D Printing Process
FITBIONIC's New Prosthetic Foot Uses Solvay's TorlonŽ PAI for Key Bearing Components
Solvay's AmodelŽ PPA and IxefŽ PARA Receive Regulatory Approval for Food-Contact Use
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Plastics
Biomaterials
Join the forum discussion at:
Hard to Handle


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address